These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9401805)

  • 21. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J; Robicsek A; Hooper DC
    Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
    Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
    Zirnstein G; Helsel L; Li Y; Swaminathan B; Besser J
    FEMS Microbiol Lett; 2000 Sep; 190(1):1-7. PubMed ID: 10981681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
    Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Vinué L; Hooper DC; Jacoby GA
    Int J Antimicrob Agents; 2018 Mar; 51(3):479-483. PubMed ID: 29360506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.
    Korten V; Huang WM; Murray BE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2091-4. PubMed ID: 7811024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.
    Blázquez R; Menasalvas A; Carpena I; Ramírez C; Guerrero C; Moreno S
    Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):503-5. PubMed ID: 10482029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae.
    Roychoudhury S; Twinem TL; Makin KM; McIntosh EJ; Ledoussal B; Catrenich CE
    J Antimicrob Chemother; 2001 Jul; 48(1):29-36. PubMed ID: 11418510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys.
    Giraud E; Leroy-Sétrin S; Flaujac G; Cloeckaert A; Dho-Moulin M; Chaslus-Dancla E
    J Antimicrob Chemother; 2001 Mar; 47(3):341-3. PubMed ID: 11222567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to fluoroquinolones in Escherichia coli isolated from poultry.
    Bazile-Pham-Khac S; Truong QC; Lafont JP; Gutmann L; Zhou XY; Osman M; Moreau NJ
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1504-7. PubMed ID: 8726027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
    Oethinger M; Kern WV; Jellen-Ritter AS; McMurry LM; Levy SB
    Antimicrob Agents Chemother; 2000 Jan; 44(1):10-3. PubMed ID: 10602715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
    Heisig P; Tschorny R
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1284-91. PubMed ID: 8092826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.